Cargando…
Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review()()
Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytokines. This...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Dermatologia
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058836/ https://www.ncbi.nlm.nih.gov/pubmed/31789270 http://dx.doi.org/10.1016/j.abd.2019.01.009 |